Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
This novel study was specifically designed for platinum-resistant recurrent ovarian cancers with PFI\<6 months and aimed to compare prognosis of patients who received cytoreductive surgery followed by chemotherapy versus chemotherapy alone.
Cytoreductive Surgery
OTHER: cytoreductive surgery
PFS, period from the end of treatment to the recurrence of disease, month 6
This novel study was specifically designed for platinum-resistant recurrent ovarian cancers with PFI\<6 months and aimed to compare prognosis of patients who received cytoreductive surgery followed by chemotherapy versus chemotherapy alone.